NO20002099D0 - 6,11-bro-erytromycinderivater - Google Patents

6,11-bro-erytromycinderivater

Info

Publication number: NO20002099D0
Authority: NO; Norway
Prior art keywords: erythromycin derivative; bridged erythromycin; bridged; derivative; erythromycin
Prior art date: 1997-10-29

Application number

NO20002099A

Other languages

English (en)

Other versions

NO20002099L (no

Inventor

Yat Sun Or

George W Griesgraber

Leping Li

Daniel T Chu

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-29

Filing date

2000-04-25

Publication date

2000-04-25

2000-04-25 Application filed by Abbott Lab filed Critical Abbott Lab

2000-04-25 Publication of NO20002099D0 publication Critical patent/NO20002099D0/no

2000-06-29 Publication of NO20002099L publication Critical patent/NO20002099L/no

Links

ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

NO20002099A 1997-10-29 2000-04-25 6,11-bro-erytromycinderivater NO20002099L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US96040097A	1997-10-29	1997-10-29
US15826998A	1998-09-22	1998-09-22
PCT/US1998/022941 WO1999021864A1 (en)	1997-10-29	1998-10-29	6,11-bridged erythromycin derivatives

Publications (2)

Publication Number	Publication Date
NO20002099D0 true NO20002099D0 (no)	2000-04-25
NO20002099L NO20002099L (no)	2000-06-29

Family

ID=26854886

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20002099A NO20002099L (no)	1997-10-29	2000-04-25	6,11-bro-erytromycinderivater

Country Status (23)

Country	Link
EP (1)	EP1027361B1 (no)
JP (1)	JP2001521038A (no)
KR (1)	KR20010031591A (no)
CN (1)	CN1278266A (no)
AR (1)	AR015986A1 (no)
AT (1)	ATE239750T1 (no)
AU (1)	AU1286799A (no)
BG (1)	BG104425A (no)
BR (1)	BR9813317A (no)
CA (1)	CA2307828A1 (no)
CO (1)	CO4990972A1 (no)
DE (1)	DE69814441T2 (no)
DK (1)	DK1027361T3 (no)
ES (1)	ES2198766T3 (no)
HU (1)	HUP0004323A2 (no)
IL (1)	IL134996A0 (no)
NO (1)	NO20002099L (no)
PL (1)	PL340253A1 (no)
PT (1)	PT1027361E (no)
SK (1)	SK6342000A3 (no)
TR (1)	TR200001140T2 (no)
TW (1)	TW486485B (no)
WO (1)	WO1999021864A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6437106B1 (en) *	1999-06-24	2002-08-20	Abbott Laboratories	Process for preparing 6-o-substituted erythromycin derivatives
US6472372B1 (en)	2000-12-06	2002-10-29	Ortho-Mcneil Pharmaceuticals, Inc.	6-O-Carbamoyl ketolide antibacterials
CA2460947A1 (en)	2001-09-17	2003-03-27	Ortho-Mcneil Pharmaceutical, Inc.	6-o-carbamate-11,12-lacto-ketolide antimicrobials
CA2469304A1 (en)	2001-12-05	2003-06-19	Ortho-Mcneil Pharmaceutical, Inc.	6-o acyl ketolide antibacterials
WO2003095466A1 (en) *	2002-05-13	2003-11-20	Enanta Pharmaceuticals, Inc.	6,11 bicyclic erythromycin derivatives
US7273853B2 (en)	2002-05-13	2007-09-25	Enanta Pharmaceuticals, Inc.	6-11 bicyclic ketolide derivatives
US6841664B2 (en) *	2002-07-25	2005-01-11	Enanra Pharmaceuticals, Inc.	6,11-4-carbon bridged ketolides
NZ536402A (en)	2002-05-13	2006-08-31	Enanta Pharm Inc	6,11 bicyclic erythromycin derivatives
US7910558B2 (en) *	2002-05-13	2011-03-22	Enanta Pharmaceuticals, Inc.	Bridged macrocyclic compounds and processes for the preparation thereof
US6753318B1 (en) *	2002-07-25	2004-06-22	Enanta Pharmaceuticals, Inc.	6,11-4-carbon bridged erythromycin derivatives
US6645941B1 (en) *	2003-03-26	2003-11-11	Enanta Pharmaceuticals, Inc.	6,11-3C-bicyclic 9a-azalide derivatives
WO2005067564A2 (en)	2004-01-07	2005-07-28	Enanta Pharmaceuticals, Inc.	6-11 bicyclic erythromycin derivatives
US7265094B2 (en)	2004-01-09	2007-09-04	Enanta Pharmaceuticals, Inc.	9N-substituted 6-11 bicyclic erythromycin derivatives
WO2005080408A1 (en) *	2004-01-23	2005-09-01	Enanta Pharmaceuticals, Inc.	Bridged macrocyclic compounds and processes for the preparation thereof
US7384921B2 (en)	2004-02-20	2008-06-10	Enanta Pharmaceuticals, Inc.	Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7384922B2 (en)	2005-05-04	2008-06-10	Enanta Pharmaceuticals, Inc.	6-11 bridged oxime erythromycin derivatives
US7589067B2 (en)	2005-10-12	2009-09-15	Enanta Pharmaceuticals, Inc.	6, 11-bridged tricyclic macrolides
US8273720B2 (en)	2007-09-17	2012-09-25	Enanta Pharmaceuticals, Inc.	6,11-bicyclolides: bridged biaryl macrolide derivatives
US11673910B2 (en)	2017-04-28	2023-06-13	Zikani Therapeutics, Inc.	Macrolides with modified desosamine sugars and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT876388E (pt) *	1995-11-08	2004-07-30	Abbott Lab	Derivados de eritromicina triciclica

1998
- 1998-10-27 CO CO98062727A patent/CO4990972A1/es unknown
- 1998-10-27 AR ARP980105375A patent/AR015986A1/es unknown
- 1998-10-29 SK SK634-2000A patent/SK6342000A3/sk unknown
- 1998-10-29 IL IL13499698A patent/IL134996A0/xx unknown
- 1998-10-29 AT AT98956314T patent/ATE239750T1/de not_active IP Right Cessation
- 1998-10-29 CN CN98810785A patent/CN1278266A/zh active Pending
- 1998-10-29 WO PCT/US1998/022941 patent/WO1999021864A1/en not_active Ceased
- 1998-10-29 DK DK98956314T patent/DK1027361T3/da active
- 1998-10-29 CA CA002307828A patent/CA2307828A1/en not_active Abandoned
- 1998-10-29 PL PL98340253A patent/PL340253A1/xx unknown
- 1998-10-29 KR KR1020007004641A patent/KR20010031591A/ko not_active Withdrawn
- 1998-10-29 HU HU0004323A patent/HUP0004323A2/hu unknown
- 1998-10-29 PT PT98956314T patent/PT1027361E/pt unknown
- 1998-10-29 EP EP98956314A patent/EP1027361B1/en not_active Expired - Lifetime
- 1998-10-29 DE DE69814441T patent/DE69814441T2/de not_active Expired - Fee Related
- 1998-10-29 BR BR9813317-9A patent/BR9813317A/pt not_active IP Right Cessation
- 1998-10-29 AU AU12867/99A patent/AU1286799A/en not_active Abandoned
- 1998-10-29 ES ES98956314T patent/ES2198766T3/es not_active Expired - Lifetime
- 1998-10-29 TR TR2000/01140T patent/TR200001140T2/xx unknown
- 1998-10-29 JP JP2000517973A patent/JP2001521038A/ja not_active Withdrawn
- 1998-11-30 TW TW087117981A patent/TW486485B/zh active
2000
- 2000-04-25 NO NO20002099A patent/NO20002099L/no not_active Application Discontinuation
- 2000-05-11 BG BG104425A patent/BG104425A/bg unknown

Also Published As

Publication number	Publication date
EP1027361B1 (en)	2003-05-07
AR015986A1 (es)	2001-05-30
IL134996A0 (en)	2001-05-20
WO1999021864A1 (en)	1999-05-06
JP2001521038A (ja)	2001-11-06
CO4990972A1 (es)	2000-12-26
PT1027361E (pt)	2003-09-30
CA2307828A1 (en)	1999-05-06
BG104425A (bg)	2001-01-31
DE69814441T2 (de)	2004-04-08
TR200001140T2 (tr)	2001-05-21
TW486485B (en)	2002-05-11
BR9813317A (pt)	2000-08-22
KR20010031591A (ko)	2001-04-16
ATE239750T1 (de)	2003-05-15
ES2198766T3 (es)	2004-02-01
DE69814441D1 (de)	2003-06-12
EP1027361A1 (en)	2000-08-16
NO20002099L (no)	2000-06-29
SK6342000A3 (en)	2000-09-12
AU1286799A (en)	1999-05-17
HUP0004323A2 (hu)	2001-02-28
PL340253A1 (en)	2001-01-29
CN1278266A (zh)	2000-12-27
DK1027361T3 (da)	2003-08-25

Legal Events

Date	Code	Title	Description
2003-06-23	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO2006016I1 (no)	2006-11-27	7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt)	2005-01-31	4,5-diaril-imidazoles 2-substituidos
ATE435861T1 (de)	2009-07-15	12,13-cyclopropan-epothilonderivate
DE69736711D1 (de)	2006-11-02	Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da)	2004-08-09	Substituerede 6,6-heterobicykliske derivater
ID29241A (id)	2001-08-16	Turunan-turunan kinolin teranelasi-1,2
DK1000048T3 (da)	2003-03-03	Substituerede 1,2,3,4-tetrahydronapthalenderivater
ATE275151T1 (de)	2004-09-15	3,6-ketal-makrolidantibiotika
FI952424L (fi)	1995-11-20	11,21-bisfenyyli-19-norpregaanijohdannaisia
ATE231847T1 (de)	2003-02-15	Substituierte 1,2,3,4- tetrahydronaphthalinderivate
DE69821009D1 (de)	2004-02-12	6,9-verbrückte erythromycin-derivate
ATE239750T1 (de)	2003-05-15	6,11-verbrückte erythromycinderivate
ID21413A (id)	1999-06-10	Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
EE04089B1 (et)	2003-08-15	1,3,4-oksadiasolooni derivaadid
LV11898A (lv)	1997-12-20	Eritromicina atvasinajumi
ATE234839T1 (de)	2003-04-15	4,5-azolo-oxindole
EP0766685A4 (en)	1997-07-16	ARYL, ALKYL, ALKENYL AND ALKINYL MACROLID
DK1068200T3 (da)	2005-06-20	2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id)	2000-07-06	Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
ID26368A (id)	2000-12-14	Turunan-turunan 2 deoksi higromisin
ATE240941T1 (de)	2003-06-15	1,25-dihydroxy-16,22,23-trisdehydro- cholecalciferol-derivate
PT984975E (pt)	2003-09-30	Derivados de eritromicina multiciclicos
BR1100453A (pt)	2006-05-09	derivados de eritromicina
ZA989848B (en)	1999-04-29	6,11-bridged erythromycin derivatives
SI1027361T1 (en)	2004-02-29	6,11-bridged erythromycin derivatives